Company Monitoring Page for Roche

latest headlines for company on cafepharma

Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll
Fierce Pharma
Thu, 03/18/21 - 11:01 am
Tags:
Horizon Therapeutics, Roche, Genentech, AbbVie, Neurocrine, employee satisfaction
Potential False Results with Roche Molecular Systems’ SARS-CoV-2 Assay
FDA Law Blog
Thu, 03/18/21 - 10:47 am
Tags:
Roche Molecular Systems, COVID-19, diagnostics, Roche
Roche launches test to monitor emerging coronavirus variants
Pharmaforum
Tue, 03/16/21 - 11:00 am
Tags:
Roche, diagnostics, COVID-19, COVID-19 variants
Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom
Endpoints
Mon, 03/15/21 - 10:50 am
Tags:
Roche, Genentech, M&A, GenMark Diagnostics, diagnostics
GSK, Novo and Roche meds hit pandemic potholes while Dupixent, Humira stood strong: analysts
Fierce Pharma
Sat, 03/13/21 - 10:19 pm
Tags:
COVID-19, pandemic, GSK, Novo Nordisk, Roche
In the latest twist to IL-6 roller coaster, Roche's Actemra fails PhIII Covid-19 Veklury combo trial
Endpoints
Thu, 03/11/21 - 10:34 am
Tags:
Roche, Actemra, clinical trials, COVID-19, COVID-19 pneumonia, Veklury
Industry-wide accelerated approval review yields four withdrawals
RAPS.org
Wed, 03/10/21 - 10:53 pm
Tags:
FDA, Bristol-Meyers Squibb, Roche, Merck, AstraZeneca, accelerated approvals
Roche joins the FDA accelerated approval revamp team, nixing a Tecentriq bladder cancer nod
Fierce Pharma
Mon, 03/8/21 - 11:12 am
Tags:
Roche, Tecentriq, bladder cancer
FDA Approves First Biologic for Rare, Debilitating Lung Disease
BioSpace
Sun, 03/7/21 - 01:35 pm
Tags:
FDA, Roche, Genentech, Actemra, SSc-ILD, biologics
Roche is gearing up to knock down an Irish plant—and it's complicated
Fierce Pharma
Thu, 03/4/21 - 11:28 pm
Tags:
Roche, Ireland, drug manufacturing
Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda
Fierce Pharma
Thu, 03/4/21 - 11:21 pm
Tags:
Pfizer, Lorbrena, non-small cell lung cancer, Novartis, Roche, Takeda
A busy year ahead for Parkinson’s disease
EP Vantage
Wed, 03/3/21 - 10:56 am
Tags:
Parkinson's Disease, drug development, AstraZeneca, Roche, Prothena, MeiraGTx, Annovis Bio, Sanofi, Alkahest, Peptron, SAGE Therapeutics
Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche
Fierce Biotech
Thu, 02/25/21 - 10:44 am
Tags:
Merck, Pandion, M&A, immune modulators, Amgen, Eli Lilly, Roche
Medtech’s haves and have-nots
EP Vantage
Wed, 02/24/21 - 10:59 am
Tags:
earnings, devices, Medtech, Medtronic, EXACT Sciences, Thermo Fisher, Abbott Labs, Roche, Qiagen, JNJ, Zimmer Biomet, Smith & Nephew, Boston Scientific
The big Covid-19 trials still to report
EP Vantage
Wed, 02/17/21 - 10:48 am
Tags:
COVID-19, clinical trials, Roche, Actemra, GSK, Synairgen, Algernon, Abivax, Corbus
Genentech Could Regain the Blindness-Related Disease Market with New Treatment
BioSpace
Sat, 02/13/21 - 11:01 pm
Tags:
Roche, Genentech, clinical trials, faricimab, age-related macular degeneration, nAMD
Versant spinout lands $80M to go 'much broader' than the old Roche partnership that birthed it
Endpoints
Thu, 02/11/21 - 10:38 pm
Tags:
Versant Ventures, Pipeline Therapeutics, Roche
Arthritis drug cuts deaths in hospitalized Covid-19 patients, major study shows
Stat
Thu, 02/11/21 - 10:50 am
Tags:
Roche, tocilizumab, COVID-19, clinical trials
Heart disease devices lead latest batch of FDA breakthrough nods
Medtech Dive
Wed, 02/10/21 - 10:19 am
Tags:
devices, FDA, cardiovascular disease, Roche, Puzzle Medical Devices, Alleviant Medical, Pedra Technology, Vascular Perfusion Solutions
Roche refreshingly cautious on Alzheimer's hopeful gantenerumab amid growing hype from rivals
Fierce Biotech
Fri, 02/5/21 - 10:52 am
Tags:
Roche, gantenerumab, Alzheimer's disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.